Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple Sclerosis
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
A Web based real world observational study in Relapsing-Remitting Multiple Sclerosis (RRMS)
population capturing outcomes reported by patients and by the physicians during 12 months
after initiating or resuming Betaseron.